Kaumaya PT - Search Results

1

Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections.

Tomaru U, Yamano Y, Nagai M, Maric D, Kaumaya PT, Biddison W, Jacobson S. Tomaru U, et al. Among authors: kaumaya pt. Nat Med. 2003 Apr;9(4):469-76. doi: 10.1038/nm845. Epub 2003 Mar 24. Nat Med. 2003. PMID: 12652294

2

Enhanced T cell responses to antigenic peptides targeted to B cell surface Ig, Ia, or class I molecules.

Casten LA, Kaumaya P, Pierce SK. Casten LA, et al. J Exp Med. 1988 Jul 1;168(1):171-80. doi: 10.1084/jem.168.1.171. J Exp Med. 1988. PMID: 2840479 Free PMC article.

3

Characteristics of peptides which compete for presented antigen-binding sites on antigen-presenting cells.

Smolenski LA, Kaumaya P, Atassi MZ, Pierce SK. Smolenski LA, et al. Eur J Immunol. 1990 May;20(5):953-60. doi: 10.1002/eji.1830200502. Eur J Immunol. 1990. PMID: 2162778

4

Antigen-presenting function of B lymphocytes.

Pierce SK, Morris JF, Grusby MJ, Kaumaya P, van Buskirk A, Srinivasan M, Crump B, Smolenski LA. Pierce SK, et al. Immunol Rev. 1988 Dec;106:149-80. doi: 10.1111/j.1600-065x.1988.tb00778.x. Immunol Rev. 1988. PMID: 3075588 Review.

5

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction.

Overholser J, Guo L, Kaumaya PTP. Overholser J, et al. Among authors: kaumaya ptp. J Vis Exp. 2023 Jul 7;(197). doi: 10.3791/65467. J Vis Exp. 2023. PMID: 37486131

6

Therapeutic Cancer Vaccines for the Management of Recurrent and Metastatic Head and Neck Cancer: A Review.

Ritter A, Koirala N, Wieland A, Kaumaya PTP, Mitchell DL. Ritter A, et al. Among authors: kaumaya ptp. JAMA Otolaryngol Head Neck Surg. 2023 Feb 1;149(2):168-176. doi: 10.1001/jamaoto.2022.4264. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36580281 Review.

7

A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx).

Guo L, Overholser J, Darby H, Ede NJ, Kaumaya PTP. Guo L, et al. Among authors: kaumaya ptp. Oncoimmunology. 2022 Oct 5;11(1):2127691. doi: 10.1080/2162402X.2022.2127691. eCollection 2022. Oncoimmunology. 2022. PMID: 36211807 Free PMC article.

8

Preclinical Studies of a Novel Human PD-1 B-Cell Peptide Cancer Vaccine PD1-Vaxx From BALB/c Mice to Beagle Dogs and to Non-Human Primates (Cynomolgus Monkeys).

Guo L, Overholser J, Good AJ, Ede NJ, Kaumaya PTP. Guo L, et al. Among authors: kaumaya ptp. Front Oncol. 2022 May 13;12:826566. doi: 10.3389/fonc.2022.826566. eCollection 2022. Front Oncol. 2022. PMID: 35646678 Free PMC article.

9

First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations.

Guo L, Kaumaya PTP. Guo L, et al. Among authors: kaumaya ptp. Br J Cancer. 2021 Jul;125(2):152-154. doi: 10.1038/s41416-021-01342-9. Epub 2021 Mar 26. Br J Cancer. 2021. PMID: 33772155 Free PMC article.

10

Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model.

Kaumaya PTP, Guo L, Overholser J, Penichet ML, Bekaii-Saab T. Kaumaya PTP, et al. Oncoimmunology. 2020 Oct 1;9(1):1818437. doi: 10.1080/2162402X.2020.1818437. Oncoimmunology. 2020. PMID: 33117602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters